Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021 7 1
Oseltamivir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/11/2020 5 3
Chlorpromazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 3 0
Saquinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 10 1
Imatinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 4 0
Triclabendazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/28/2020 1 0
Omeprazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/28/2020 1 0
Carmofur Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/28/2020 2 0
Excel (.xslx) CSV (.csv)